Featured

InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

http://www.cannabisfn.com/inmed-announces-positive-pre-clinical-data-ocular-hydrogel-formulation-using-biosynthesized-cannabinoid/

VANCOUVER , Oct. 24, 2017 /CNW/ –¬†InMed Pharmaceuticals, Inc.¬†(“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF ), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies , announced today results from a study co-sponsored by InMed (Dr. Sazzad Hossain , Chief Scientific Officer) and the University of British Columbia (laboratories […]

The post InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid appeared first on CannabisFN.

Show More

Related Articles

Close
Close